Cargando…

Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?

Detalles Bibliográficos
Autor principal: Weber, Martin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360792/
https://www.ncbi.nlm.nih.gov/pubmed/25798446
http://dx.doi.org/10.1212/NXI.0000000000000084
_version_ 1782361584537960448
author Weber, Martin S.
author_facet Weber, Martin S.
author_sort Weber, Martin S.
collection PubMed
description
format Online
Article
Text
id pubmed-4360792
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-43607922015-03-20 Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS? Weber, Martin S. Neurol Neuroimmunol Neuroinflamm Editorial Lippincott Williams & Wilkins 2015-03-12 /pmc/articles/PMC4360792/ /pubmed/25798446 http://dx.doi.org/10.1212/NXI.0000000000000084 Text en © 2015 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-Noncommercial No Derivative 3.0 License, which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.
spellingShingle Editorial
Weber, Martin S.
Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
title Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
title_full Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
title_fullStr Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
title_full_unstemmed Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
title_short Is intrathecal anti-CD20 an option to target compartmentalized CNS inflammation in progressive MS?
title_sort is intrathecal anti-cd20 an option to target compartmentalized cns inflammation in progressive ms?
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4360792/
https://www.ncbi.nlm.nih.gov/pubmed/25798446
http://dx.doi.org/10.1212/NXI.0000000000000084
work_keys_str_mv AT webermartins isintrathecalanticd20anoptiontotargetcompartmentalizedcnsinflammationinprogressivems